Dr John R Minner, MD | |
169 Ashley Ave, Room 202 Main Hospital Msc333, Charleston, SC 29425-8905 | |
(843) 792-9162 | |
Not Available |
Full Name | Dr John R Minner |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 169 Ashley Ave, Charleston, South Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194174649 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | LL39656 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John R Minner, MD 169 Ashley Ave, Room 202 Main Hospital Msc333, Charleston, SC 29425-8905 Ph: (843) 792-9162 | Dr John R Minner, MD 169 Ashley Ave, Room 202 Main Hospital Msc333, Charleston, SC 29425-8905 Ph: (843) 792-9162 |
News Archive
Stemline Therapeutics, Inc. today announced that data from pre-clinical studies of its IL-3R targeting agents, SL-401 and SL-501, in both in vitro and animal models of human chronic myeloid leukemia (CML) have been selected for poster presentation at the upcoming 51st Annual Meeting of the American Society of Hematology (ASH), to be held in New Orleans from December 5-8, 2009.
The Melbourne drug company Biota has announced trials of a drug to treat the human rhinovirus (HRV) which is the main culprit in the common cold.
A new drug may boost the effectiveness of a widely used treatment for patients with non-Hodgkin lymphoma (NHL), while simultaneously overcoming drug resistance in those patients.
New research just out in the journal Science Translational Medicine opens the door for the development of treatments capable of stopping Alzheimer's disease (AD) before its first symptoms, that is to say before any crucial damage occurs. In fact, if AD is a devastating disorder it is also an extremely slow one; it takes more than 10 years for the first symptoms to appear making this preclinical period (pre-symptoms) the ideal time to intervene.
Researchers in the United States have shown that an engineered soluble decoy receptor tightly binds the spike protein of severe acute respiratory syndrome (SARS)-associated viruses. This could potentially provide protection against zoonotic betacoronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
› Verified 5 days ago
Christine Lloyd, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 198 Rutledge Ave, Charleston, SC 29403 Phone: 843-577-5012 Fax: 843-722-8368 | |
Robert Joseph Adams, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 Fax: 843-792-2484 | |
Kevin Michael Gray, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Melanie Anne Lobel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Billy Beck, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 109 Bee St, Charleston, SC 29401 Phone: 843-577-5011 | |
Ciara Monet Styles, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-9888 | |
Alexandra Goslow, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-9888 |